$CBT
Cabot Corporation
XNYS•Materials•Miscellaneous Chemical Products
$75.41
▼-2.20%-$1.70
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is CBT down today? It is at $75.41 (-2.20%), and our scanner flagged it 18 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CBT spikes, and full due diligence on CBT — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CBT 18 times in the last 30 days. Create a free account to track $CBT, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CBT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CBT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystCabot Corporation Appoints Steve Delahunt as Interim Chief Financial Officer, from an SEC filing. Read it →Latest filing3Initial insider ownership (Form 3)Oct 7, 2026 · todayA share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Keohane Sean D Officer | Sold (automatic/other) | -135K 0.3% of company | sold 25% | 404K | $11.5M at $85.00 | Aug 28, 26 |
Keohane Sean D Officer | Other | 135K 0.3% of company | added 33% | 539K | $6.7M at $50.00 | Aug 28, 26 |
Keohane Sean D Officer | Sold (automatic/other) | -3K | sold 1.0% | 289K | $238K at $85.50 | Aug 24, 26 |
Keohane Sean D Officer | Other | 3K | added 1.0% | 292K | $139K at $50.00 | Aug 24, 26 |
Keohane Sean D Officer | Sold (automatic/other) | -92K 0.2% of company | sold 19% | 404K | $7.9M at $86.41 | Aug 7, 26 |
Keohane Sean D Officer | Other | 92K 0.2% of company | added 23% | 496K | $5.7M at $62.24 | Aug 7, 26 |
Kirby William C. Director | Acquired (grant/award) | +486 | added 1.8% | 28K | n/a | Jan 8, 26 |
Yan Christine Y Director | Acquired (grant/award) | +2K | added 15% | 17K | n/a | Jan 8, 26 |
Morrow Michael M Director | Acquired (grant/award) | +2K | added 11% | 22K | n/a | Jan 8, 26 |
Arnold Cynthia A Director | Acquired (grant/award) | +2K | added 13% | 20K | n/a | Jan 8, 26 |
Wilson Frank Anders Director | Acquired (grant/award) | +2K | added 14% | 19K | n/a | Jan 8, 26 |
Nathoo Raffiq Director | Acquired (grant/award) | +2K | added 33% | 9K | n/a | Jan 8, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in miscellaneous chemical products, closest in size first.
Here is the latest on CBT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CBT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CBT last traded at $75.41, down 2.20% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Cabot Corporation (CBT) is next expected to report earnings on Monday, November 2, 2026, about 26 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. CBT currently has a dividend yield of about 2.45% ($1.89 per share per year). Dividend figures can change; this is not investment advice.
The CBT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CBT 18 times in the last 30 days.
CBT (Cabot Corporation) trades on XNYS, with a market cap of about $3.98B in the MISCELLANEOUS CHEMICAL PRODUCTS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CBT for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CBT discussion
Sign in to ask a question or join the discussion.